title: MMTV promoter-regulated caveolin-1 overexpression yields defective parenchymal epithelia in multiple exocrine organs of transgenic mice.
abstract: Caveolin-1 (Cav-1) is a major structural protein of caveolae, specialized plasma membrane invaginations that are involved in a cell-specific fashion in diverse cell activities such as molecular transport, cell adhesion, and signal transduction. In normal adult mammals, Cav-1 expression is abundant in mesenchyme-derived cells but relatively low in epithelial parenchyma. However, epithelial Cav-1 overexpression is associated with development and/or progression of many carcinomas. In this study, we generated and characterized a transgenic mouse model of Cav-1 overexpression under the control of a mouse mammary tumor virus (MMTV) long terminal-repeat promoter, which is predominantly expressed in specific epithelial cells. The MMTVcav-1(+) transgenic mice were fertile, and females bore litters of normal size with no obvious developmental abnormalities. However, by age 11months, the MMTVcav-1(+) mice demonstrated overtly different phenotypes in multiple exocrine organs when compared with their nontransgenic MMTVcav-1(-) littermates. Cav-1 overexpression in MMTVcav-1(+) mice produced organ-specific abnormalities, including hypotrophy of mammary glandular epithelia, bronchiolar epithelial hyperplasia and atypia, mucous-cell hyperplasia in salivary glands, elongated hair follicles and dermal thickening in the skin, and reduced accumulation of enzymogen granules in pancreatic acinar cells. In addition, the MMTVcav-1(+) transgenic mice tended to have a greater incidence of malignant tumors, including lung and liver carcinomas and lymphoma, than their MMTVcav-1(-) littermates. Our results indicate that Cav-1 overexpression causes organ-specific, age-related epithelial disorders and suggest the potential for increased susceptibility to carcinogenesis.
authors.affiliation: Department of Genitourinary Medical Oncology-Research, Unit 18-3, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030-4009, USA. guangyang@mdanderson.org
authors.forename: Guang
authors.initials: G
authors.lastname: Yang
authors.forename: Sanghee
authors.initials: S
authors.lastname: Park
authors.forename: Guangwen
authors.initials: G
authors.lastname: Cao
authors.forename: Alexei
authors.initials: A
authors.lastname: Goltsov
authors.forename: Chengzhen
authors.initials: C
authors.lastname: Ren
authors.forename: Luan D
authors.initials: LD
authors.lastname: Truong
authors.forename: Francesco
authors.initials: F
authors.lastname: Demayo
authors.forename: Timothy C
authors.initials: TC
authors.lastname: Thompson
mesh_terms: D000015:Abnormalities, Multiple / Q000235:genetics*; D000818:Animals; D051242:Caveolin 1 / Q000235:genetics*; D002478:Cells, Cultured; D004848:Epithelium / Q000378:metabolism / Q000473:pathology*; D005088:Exocrine Glands / Q000002:abnormalities*; D005260:Female; D005786:Gene Expression Regulation / Q000502:physiology*; D006965:Hyperplasia; D015994:Incidence; D008113:Liver Neoplasms / Q000235:genetics; D008175:Lung Neoplasms / Q000235:genetics; D008297:Male; D008321:Mammary Glands, Animal / Q000002:abnormalities; D008324:Mammary Tumor Virus, Mouse / Q000235:genetics*; D051379:Mice; D008822:Mice, Transgenic; D011401:Promoter Regions, Genetic / Q000235:genetics*; D012867:Skin / Q000378:metabolism / Q000473:pathology
chemical_list: D051242:Caveolin 1
references.citation: Am J Physiol. 1998 Nov;275(5):L843-51
references.pmid: 9815100
references.citation: Mol Cancer Res. 2009 Sep;7(9):1446-55
references.pmid: 19737975
references.citation: Am J Pathol. 2003 Apr;162(4):1241-8
references.pmid: 12651616
references.citation: Genomics. 2006 Aug;88(2):163-72
references.pmid: 16714093
references.citation: Arthritis Res Ther. 2008;10(4):R87
references.pmid: 18681962
references.citation: J Biol Chem. 2001 Apr 20;276(16):13442-51
references.pmid: 11278309
references.citation: Cancer Res. 2007 Aug 15;67(16):7675-85
references.pmid: 17699771
references.citation: Prostate Cancer Prostatic Dis. 2010 Mar;13(1):6-11
references.pmid: 19581923
references.citation: Clin Cancer Res. 1998 Aug;4(8):1873-80
references.pmid: 9717814
references.citation: J Biol Chem. 2005 Jul 1;280(26):25134-45
references.pmid: 15802273
references.citation: Br J Dermatol. 2005 Sep;153(3):506-13
references.pmid: 16120134
references.citation: Br J Cancer. 2002 Nov 4;87(10):1140-4
references.pmid: 12402154
references.citation: BJU Int. 2004 Feb;93(3):291-6
references.pmid: 14764125
references.citation: Cancer. 2002 Feb 15;94(4):929-33
references.pmid: 11920460
references.citation: Am J Pathol. 2002 May;160(5):1745-54
references.pmid: 12000726
references.citation: J Biol Chem. 2004 Jun 4;279(23):24745-56
references.pmid: 15044451
references.citation: Cancer Res. 2003 Jun 1;63(11):2864-71
references.pmid: 12782592
references.citation: Prostate. 1997 Nov 1;33(3):157-63
references.pmid: 9365542
references.citation: Science. 2001 Sep 28;293(5539):2449-52
references.pmid: 11498544
references.citation: Neurobiol Aging. 2004 Jul;25(6):753-9
references.pmid: 15165700
references.citation: Lung Cancer. 2003 Nov;42(2):195-202
references.pmid: 14568687
references.citation: Exp Mol Pathol. 2008 Apr;84(2):131-40
references.pmid: 18358473
references.citation: Am J Pathol. 2001 Mar;158(3):833-9
references.pmid: 11238032
references.citation: Nat Cell Biol. 1999 Oct;1(6):369-75
references.pmid: 10559965
references.citation: Urol Oncol. 2003 May-Jun;21(3):191-6
references.pmid: 12810205
references.citation: Clin Cancer Res. 2001 Nov;7(11):3519-25
references.pmid: 11705871
references.citation: Am J Pathol. 2003 Jun;162(6):2029-39
references.pmid: 12759258
references.citation: Am J Physiol Cell Physiol. 2005 Mar;288(3):C494-506
references.pmid: 15692148
references.citation: Mol Biol Cell. 2003 Mar;14(3):1027-42
references.pmid: 12631721
references.citation: Cancer Biol Ther. 2008 Aug;7(8):1212-25
references.pmid: 18458534
references.citation: Cancer Lett. 2004 Oct 8;214(1):121-8
references.pmid: 15331180
references.citation: Cell Cycle. 2008 Jul 15;7(14):2257-67
references.pmid: 18635971
references.citation: Proc Natl Acad Sci U S A. 1995 Feb 28;92(5):1381-5
references.pmid: 7877987
references.citation: Cancer Res. 2002 Dec 1;62(23):6973-80
references.pmid: 12460915
references.citation: Cell. 1990 Jun 29;61(7):1329-37
references.pmid: 2364430
references.citation: J Pathol. 2004 May;203(1):584-93
references.pmid: 15095482
references.citation: Urology. 2008 Jul;72(1):167-71
references.pmid: 18384856
references.citation: J Clin Invest. 2001 Dec;108(11):1553-61
references.pmid: 11733547
references.citation: Cancer Res. 2006 Oct 15;66(20):9937-47
references.pmid: 17047056
references.citation: Prostate. 2007 May 1;67(6):614-22
references.pmid: 17299799
references.citation: J Virol. 1987 Oct;61(10):3013-9
references.pmid: 3041021
references.citation: Int J Radiat Biol. 2008 Mar;84(3):177-89
references.pmid: 18300018
references.citation: Cancer Res. 1999 Nov 15;59(22):5719-23
references.pmid: 10582690
references.citation: Br J Cancer. 2008 Jul 22;99(2):327-34
references.pmid: 18612310
references.citation: J Urol. 2004 Aug;172(2):718-22
references.pmid: 15247769
references.citation: Mol Endocrinol. 1988 Feb;2(2):143-7
references.pmid: 2840570
references.citation: Cell Cycle. 2009 Aug;8(15):2420-4
references.pmid: 19556867
references.citation: J Biol Chem. 2001 Oct 12;276(41):38121-38
references.pmid: 11457855
references.citation: Mol Cell Biol. 2002 Apr;22(7):2329-44
references.pmid: 11884617
references.citation: Mol Biol Cell. 2002 Jul;13(7):2502-17
references.pmid: 12134086
references.citation: Oncogene. 1998 Mar;16(11):1391-7
references.pmid: 9525738
references.citation: Gynecol Oncol. 2001 May;81(2):166-71
references.pmid: 11330944
references.citation: Cell Signal. 2008 Jul;20(7):1313-9
references.pmid: 18434090
references.citation: Urology. 2001 Nov;58(5):811-4
references.pmid: 11711373
references.citation: Hum Pathol. 2007 Jun;38(6):830-41
references.pmid: 17316758
references.citation: Cancer. 2007 Apr 15;109(8):1523-31
references.pmid: 17342767
references.citation: J Biol Chem. 2002 Nov 1;277(44):41295-8
references.pmid: 12189159
references.citation: Br J Cancer. 2004 Aug 31;91(5):959-65
references.pmid: 15305200
references.citation: Am J Pathol. 2009 Apr;174(4):1172-90
references.pmid: 19342371
references.citation: Br J Cancer. 2002 Mar 18;86(6):912-6
references.pmid: 11953823
references.citation: Cancer Res. 2004 Feb 1;64(3):969-76
references.pmid: 14871827
references.citation: Biochem Biophys Res Commun. 2004 Jul 2;319(3):974-9
references.pmid: 15184077
references.citation: EMBO J. 1998 Nov 16;17(22):6633-48
references.pmid: 9822607
references.citation: Cancer. 2003 Mar 1;97(5):1225-33
references.pmid: 12599229
references.citation: Am J Pathol. 2002 Nov;161(5):1647-56
references.pmid: 12414512
references.citation: J Oral Pathol Med. 2003 Sep;32(8):461-7
references.pmid: 12901727
references.citation: Mol Cell Biol. 2003 Dec;23(24):9389-404
references.pmid: 14645548
references.citation: Cancer Res. 2000 Oct 15;60(20):5870-8
references.pmid: 11059785